Determinants of Patients' Uptake of Therapeutic Education Programme

NCT03255863 | Completed

• 2 other identifiers: 2015_702016-A02057-44
• Study Type: interventional
• Target: 459
• Locations: 1 country
• Sites: 1

Brief Summary

Therapeutic Patient Education (TPE) refers to programs that help patients to manage life with a chronic disease in the best possible way. In spite of the effectiveness of Therapeutic Patient Education, few patients uptake TPE when it is proposed to them. Therefore, our main aim was to identify patients' beliefs that will predict patients' uptake of TPE. According to the Health Belief Model, patient will participate in TPE if they perceive their disease as a serious threat (with possible serious complications), but which can be controlled however, and that TPE is efficient and represents little burden. Secondary aims are as follows:

1. 1.To test whether the way TPE is presented to patients impact patients' decision to uptake TPE. The way TPE is presented comprises the time between diagnosis and the proposal of TPE, whether patient is a remission or crisis period in the disease, the time between the proposal and the next TPE session, and what is said by healthcare professionals to present TPE.
2. 2.To test whether healthcare professionals' empathy impact patients' decision to participate in TPE
3. 3.To test whether patients' intention to participate in TPE will predict their actual participation.

Conditions

Chronic Disease; Patient Education as Topic; Patient Adherence; Empathy; Quality of Healthcare

Keywords

Psychological Theory

Outcome Measures

Primary Outcomes (1)

• Patient's intention to participated in TPE by a questionnaire based on the Health Belief Model

  Patient's participation in TPE : yes or no Participation is defined as the patient's intention to come expressly to the hospital for a first appointment dedicated to therapeutic education. The main variables of the HBM will be analyzed: perceived threat of the pathology, perceived benefits and barriers to TPE, perceived patient control of its pathology.

  Baseline (after TPE proposal)

Secondary Outcomes (5)

• Time limit of first proposition in TPE

  Baseline

• Timeout of first participation in TPE

  Baseline

• Medical context in which TPE is proposed

  Baseline

• Consultation And Relational Empathy (CARE) questionnaire

  Baseline

• Visual analog scale for intention to participated

  Baseline

Study Arms (1)

Questionnaire

OTHER

Auto and hetero questionnaire

Other: Questionnaire

Interventions

Questionnaire OTHER

Patient Self reported questionnaire filled in.

Questionnaire

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients to whom TPE was proposed in diabetes, hemophilia, obesity, cardiac failure, chronic inflammatory bowel disease, parkinson, rare diseases, epilepsy, peripheral arterial diseases
• Belong to a social security scheme
• Pregnant women to whom TPE for gestational diabetes is proposed

You may not qualify if:

• Cognitive impairment declared by healthcare professionals
• Inpatients
• Patients for whom TPE is coupled with rehabilitation
• Psychiatric disorders
• Patients who cannot give informed consent
• Patients in jail

Sponsors & Collaborators

• University Hospital, Lille: lead
• Ministry of Health, France: collaborator

Study Sites (1)

Hôpital Claude Huriez, CHU

Lille, France

Location

MeSH Terms

Conditions

Chronic Disease; Patient Compliance

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Patient Acceptance of Health Care; Treatment Adherence and Compliance; Health Behavior; Behavior

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Maryline Bourgoin

  University Hospital, Lille

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 16, 2017
• First Posted: August 21, 2017
• Study Start: December 20, 2017
• Primary Completion: September 9, 2020
• Study Completion: September 9, 2020
• Last Updated: October 17, 2022

Record last verified: 2020-08

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)